IIT-Hyderabad develops AI-based Covid-19 test kit priced at ₹600
One of the biggest hurdles in treating Covid-19 patients is the cost of the screening test, which can go up to ₹4,500-6,000 depending on the availability of the test kits.
A researcher at the Indian Institute of Technology (IIT-Hyderabad) has come out with a test kit that would cost only ₹600 per test. An IIT-H spokesperson said the cost will come down further to ₹350 when volumes go up.
Intellipaat Artificial Intelligence training in Hyderabad is an industry-designed course for learning TensorFlow, artificial neural network, perceptron in the neural network, transfer learning in machine learning, backpropagation for training networks through hands-on projects and case studies. Get the best online artificial Intelligence Training in Hyderabad from Artificial Intelligence certified experts. This is created in collaboration with IBM.
Powered by Artificial Intelligence (AI), the test kit would give the results in 20 minutes, breaking another barrier in the treatment of the viral infection. “The test kit has already been field-tested at ESIC Medical College and Hospital in Hyderabad to ascertain its efficiency,” an IIT-H spokesperson said.
“It can be transported quickly, enabling the test to be conducted at the point-of-care. A major benefit of this testing kit is that it does not require RT-PCR (Reverse Transcription Polymerase Chain Reaction),” he said.
The testing kit was developed by a team led by Shiv Govind Singh of the Department of Electrical Engineering at IIT-H. Suryasnata Tripathy, a postdoctoral fellow, and Patta Supraja, a fourth-year doctoral student, were among Shiv Govind Singh’s research team.
“Once the testing kit is mass-produced, it will enable us to scale-up testing for Covid-19 suspects in a widespread manner,” BS Murty, Director, IIT Hyderabad, said.
The unique feature of the testing kit includes identifying the unique sequence of the conserved regions of the Covid-19 genome and detecting it. The team also developed AI tools to capture extensive data points to minimize the errors in decision making.
The team has sought approval of the Indian Council of Medical Research (ICMR) for mass production of the test kit.